Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Alzheimer's Disease Tau Platform Clinical Trial

NCT06957418 is registered in ClinicalTrials.gov with Paul S. Aisen as lead sponsor.

NCT NCT06957418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06957418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Alzheimer's Disease Tau Platform Clinical Trial
Lead sponsor
Paul S. Aisen
Phase
Phase 2
Overall status
Recruiting
Start date
July 6, 2026
Completion date
August 31, 2028
Enrollment
900 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, preclinical alzheimer's disease, prodromal alzheimer's disease